JT Stratford LLC’s Immunocore IMCR Stock Holding History

JT Stratford LLC’s Portfolio IMCR Stock Details IMCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5,782	Closed	-$210K	–	317
2025 Q3	$210K	Buy	+5,782	New	+$196K	0.03%	295

Other funds holding IMCR

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

JT Stratford LLC's IMCR Position: Q4 2025 in Review

JT Stratford LLC sold out of Immunocore (IMCR) in Q4 2025, closing a stake of 5,782 shares — an estimated $210K sold.

JT Stratford LLC first reported a position in IMCR in Q3 2025 and held it in 1 quarter. The position peaked at $210K in Q3 2025. 149 funds tracked by Wall St. Rank hold IMCR as of Q4 2025.

JT Stratford LLC reported no remaining Immunocore position as of Q4 2025 after selling out during the quarter.
JT Stratford LLC sold 5,782 Immunocore shares in Q4 2025, an estimated $210K.
JT Stratford LLC first reported a position in Immunocore in Q3 2025 and held it in 1 quarter.
JT Stratford LLC's Immunocore position peaked at $210K in Q3 2025.
149 funds tracked by Wall St. Rank held Immunocore as of Q4 2025.

Based on JT Stratford LLC's 13F filing for Q4 2025, filed 12 Feb 2026.